Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease

International Journal of Developmental Neuroscience

Volumn 16, Issue 7-8, 1998, Pages 737-753

  Mattson, Mark P ^a,b   Pedersen, Ward A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLUCOSE TRANSPORTER; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE LIPID; PRESENILIN 1; PRESENILIN 2; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; CALCIUM HOMEOSTASIS; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; FOREBRAIN; HUMAN; LIPID PEROXIDATION; NERVE CELL DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL SURVIVAL; HUMANS; NEURONS; OXIDATIVE STRESS; PROSENCEPHALON; REACTIVE OXYGEN SPECIES;

EID: 0032454039     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(98)00082-3     Document Type: Article

References (99)

1. Abe, E., Casamenti, F., Giovannelli, L., Scali, C. and Pepeu, G., Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res., 1994, 636, 162-164.
2. 2+ accumulation. Proc. Natl Acad. Sci. U.S.A., 1995, 92, 9328-9332.
3. Bartus, R. T., Dean, R. L., Beer, B. and Lippa, A. S., The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 214, 408-417.
4. Beckman, J. S. and Crow, J. P., Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans., 1993, 21, 330-334.
5. Berridge, M. J., Inositol trisphosphate and calcium signaling. Ann. N.Y. Acad. Sci., 1995, 766, 31-43.
6. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P. and Davis, K. L., Neurochemical correlates of dementia severity in Alzheimer's disease : relative importance of the cholinergic deficits. J. Neurochem., 1995, 64, 749-760.
7. Blanc, E. M., Toborek, M., Mark, R. J., Hennig, B. and Mattson, M. P., Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurochem., 1997, 68, 1870-1881.
8. q/11. J. Neurochem., 1997, 69, 570-580.
9. Blanc, E. M., Keller, J. N., Fernandez, S. and Mattson, M. P., 4-hydroxynonenal, a lipid peroxidation product, inhibits glutamate transport in astrocytes. Glia, 1998, 22, 149-160.
10. Blass, J. P., Gibson, G. E. and Hoyer, S., Metabolism of the aging brain. In The Aging Brain, Mattson, M. P. and Geddes, J. W. eds. JAI Press, Greenwich, CT. Adv. Cell Aging Gerontol., 1997, 2, 109-128.
11. Bruce, A. J., Bose, S., Fu, W., Butt, C. M., Mirault, M.-E., Taniguchi, N. and Mattson, M. P., Amyloid β-peptide alters the profile of antioxidant enzymes in hippocampal cultures in a manner similar to that observed in Alzheimer's disease. Pathogenesis, 1997, 1, 15-30.
12. Bruce-Keller, A. J., Li, Y.-J., Lovell, M. A., Kraemer, P. J., Gary, D. S., Brown, R. R., Markesbery, W. R. and Mattson, M. P., 4-hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol., 1998, 57, 257-267.
13. Bruce-Keller, A. J., Umberger, G., McFall, R. and Mattson, M. P., Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. (submitted).
14. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M. P. and Carney, J., β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun., 1994, 200, 710-715.
15. Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. and Floyd, R. A., Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl Acad. Sci. U.S.A., 1991, 88, 3633-3636.
16. Cheng, B., Christakos, S. and Mattson, M. P., Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron, 1994, 12, 139-153.
17. Collerton, D., Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience, 1986, 19, 1-28.
18. m GTPase activity in aging and Alzheimer's disease : implications for altered signal transduction. Brain Res., 1994, 664, 54-60.
19. Dutar, P., Bassant, M. H., Senut, M. C. and Lamour, Y., The septohippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev., 1995, 75, 393-427.
20. Everitt, B. J. and Robbins, T. W., Central cholinergic systems and cognition. Annu. Rev. Psychol., 1997, 48, 649-684.
21. Exton, J. H., Role of G proteins in activation of phosphoinositide phospholipase C. Adv. Second Messenger Phosphoprotein Res., 1993, 28, 65-72.
22. 2 hydrolysis in Alzheimer's disease. Life Sci., 1993, 53, PL439-444.
23. Fisher, S. K., Heacock, A. M. and Agranoff, B. W., Inositol lipids and signal transduction in the nervous system: an update. J. Neurochem., 1992, 58, 18-38.
24. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature, 1996, 379, 74-78.
25. Furukawa, K., Sopher, B., Rydel, R. E., Begley, J. G., Martin, G. M. and Mattson, M. P., Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted APP is conferred by a C-terminal heparin-binding domain. J. Neurochem., 1996, 67, 1882-1896.
26. Furukawa, K., Guo, Q., Schellenberg, G. D. and Mattson, M. P., Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res., 1998, 52, 618-624.
27. Gallagher, M., Animal models of memory impairment. Philos. Trans. R. Soc. Lond. B Biol. Sci., 1997, 352, 1711-1717.
28. Gerlach, M., Ben-Shachar, D., Riederer, P. and Youdim, M. B., Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem., 1994, 63, 793-807.
29. Giovannelli, L., Casamenti, F., Cacali, C., Bartolini, L. and Pepeu, G., Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into rat nucleus basalis. Neuroscience, 1995, 66, 781-792.
30. Good, P. F., Werner, P., Hsu, A., Olanow, C. W. and Perl, D. P., Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol., 1996, 149, 21-28.
31. Goodman, Y. and Mattson, M. P., Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol., 1994, 128, 1-12.
32. Goodman, Y., Bruce, A. J., Cheng, B. and Mattson, M. P., Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem., 1996, 66, 1836-1844.
33. Gremo, F., Sogos, V., Ennas, M. G., Meloni, A., Persichini, T., Colasanti, M. and Lauro, G. M., Features and functions of human microglia cells. Adv. Exp. Med. Biol., 1997, 429, 79-97.
34. Guo, Q., Furukawa, K., Sopher, B. L., Pham, D. G., Robinson, N., Martin, G. M. and Mattson, M. P., Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport, 1996, 8, 379-383.
35. Guo, Q., Sopher, B. L., Pham, D. G., Furukawa, K., Robinson, N., Martin, G. M. and Mattson, M. P., Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci., 1997, 17, 4212-4222.
36. Guo, Q., Christakos, S., Robinson, N. and Mattson, M. P., Calbindin blocks and pro-apoptotic actions of mutant presenilin-1 : reduced oxidative stress and preserved mitochondrial functions. Proc. Natl Acad. Sci. U.S.A., 1998, 95, 3227-3232.
37. Guo, Q., Robinson, N. and Mattson, M. P., Secreted APPα counteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis. J. Biol. Chem., 1998, 273, 12,341-12,351.
38. Guo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M. and Mattson, M. P., Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock in mice. Nature Med., 1999, 5, 101-107.
39. Hardy, J., Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci., 1997, 20, 154-159.
40. Harkany, T., Lengyel, Z., Soos, K., Penke, B., Luiten, P. G. M. and Gulya, K., Cholinotoxic effects of b-amyloid1-42 peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res., 1995, 695, 71-75.
41. Hoshi, M., Takashima, A., Murayama, M., Yasutake, K., Yoshida, N., Ishiguro, K., Hoshino, T. and Imahori, K., Nontoxic amyloid β peptide 1-42 suppresses acetylcholine synthesis. J. Biol. Chem., 1997, 272, 2038-2041.
42. Ishida, A., Furukawa, K., Keller, J. N. and Mattson, M. P., Secreted form of β-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices. NeuroReport, 1997, 8, 2133-2137.
43. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc. Natl Acad. Sci. U.S.A., 1994, 91, 534-538.
44. Itoh, A., Nitta, A., Nadai, M., Nishimura, K., Hirose, M., Hasegawa, T. and Nabeshima, T., Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem., 1996, 66, 1113-1117.
45. Izquierdo, I. and Medina, J. H., Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol. Learn. Mem., 1995, 63, 19-32.
46. Jope, R. S., Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease. Alzheimer's Dis. Rev., 1996, 1, 2-14.
47. Jope, R. S., Song, L. and Powers, R., Agonist-induced, GTP-dependent phosphoinositide hydrolysis in postmortem human brain membranes. J. Neurochem., 1994, 62, 180-186.
48. Joseph, J. A., Algeri, S., De-Cesare, A., Comuzio, M., Erat, S., Kelly, J., Cagnotto, A. and Mennini, T., A reduced calorie-high fiber diet retards age-associated decreases in muscarinic receptor sensitivity. Neurobiol. Aging, 1995, 16, 607-612.
49. Kar, S., Seto, D., Gaudreau, P. and Quirion, R., β-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal formation. J. Neurosci., 1996, 16, 1034-1040.
50. Kar, S., Issa, A. M., Seto, D., Auld, D. S., Collier, B. and Quirion, R. J., Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J. Neurochem., 1998, 70, 2179-2187.
51. Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G. and Mattson, M. P., Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide : role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem., 1997, 69, 273-284.
52. +-ATPase activity, glucose transport and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res., 1997, 50, 522-530.
53. Keller, J. N., Kindy, M. S., Holtsberg, F. W., St Clair, D. K., Yen, H.-C., Germeyer, A., Steiner, S. M., Bruce-Keller, A. J., Hutchins, J. B. and Mattson, M. P., Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci., 1998, 18, 687-697.
54. Kelly, J., Furukawa, K., Barger, S. W., Mark, R. J., Rengen, M. R., Blanc, E. M., Roth, G. S. and Mattson, M. P., Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl Acad. Sci. U.S.A., 1996, 93, 6753-6758.
55. Koeppen, A. H., The history of iron in the brain. J. Neurol. Sci., 1995, 134 Suppl, 1-9.
56. Kruman, I., Bruce, A. J., Bredesen, D. E., Waeg, G. and Mattson, M. P., Evidence of 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci., 1997, 17, 5089-5100.
57. Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E., Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem., 1996, 271, 4077-4081.
58. Li, X., Song, L. and Jope, R. S., Cholinergic stimulation of AP-1 and NF-κB transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma : relationship to phosphoinositide hydrolysis. J. Neurosci., 1996, 16, 5914-5922.
59. Li, X., Song, L. and Jope, R. S., Glutathione depletion exacerbates impairment by oxidative stress of phosphoinositide hydrolysis, AP-1, and NF-κB activation by cholinergic stimulation. Mol. Brain Res., 1998, 53, 196-205.
60. Lovell, M. A., Ehmann, W. D., Butler, S. M. and Markesbery, W. R., Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology, 1995, 45, 1594-1601.
61. Lovell, M. A., Ehmann, W. D., Mattson, M. P. and Markesbery, W. R., Elevated 4-hydroxynonenal levels in ventricular fluid in Alzheimer's disease. Neurobiol. Aging, 1997, 18, 457-461.
62. 2+ homeostasis and cell death. J. Neurosci., 1995, 15, 6239-6249.
63. Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K. and Mattson, M. P., A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem., 1997, 68, 255-264.
64. Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K., Mattson, M. P., Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons : involvement of membrane lipid peroxidation. J. Neurosci., 1997, 17, 1046-1054.
65. Mattson, M. P., Cheng, B., Culwell, A., Esch, F., Lieberburg, I. and Rydel, R. E., Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron, 1993, 10, 243-254.
66. Mattson, M. P., Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol., 1994, 25, 439-450.
67. Mattson, M. P., Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev., 1997, 77, 1081-1132.
68. Mattson, M. P., Robinson, N. and Guo, Q., Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport, 1997, 8, 3817-3821.
69. Mattson, M. P., Goodman, Y., Luo, H., Fu, W., Furukawa, K., Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis : evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res., 1997, 49, 681-697.
70. Mattson, M. P., Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci., 1998, 21, 53-57.
71. Mattson, M. P., Begley, J. G. and Keller, J. N., Evidence for synaptic apoptosis. Exp. Neurol., 1998, p. 153, 35-48.
72. Mattson, M. P. and Begley, J. G., Amyloid β-peptide induces apoptosis-related events in synapses and dendrites. Brain Res., 1998, 807, 167-176.
73. Maurice, T., Lockhart, B. P. and Privat, A., Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res., 1996, 706, 181-193.
74. McGeer, P. L. and McGeer, E. G., The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev., 1995, 21, 195-218.
75. Meier-Ruge, W. and Bertoni-Freddari, C., The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Rev. Neurosci., 1996, 7, 1-19.
76. Minghetti, L. and Levi, G., Microglia as effector cells in brain damage and repair : focus on prostanoids and nitric oxide. Prog. Neurobiol., 1998, 54, 99-125.
77. Moccoci, P., MacGarvey, M. S. and Beal, M. F., Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol., 1994, 36, 747-751.
78. Morris, C. M., Kerwin, J. M. and Edwardson, J. A., Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration, 1994, 3, 267-275.
79. Nabeshima, T. and Nitta, A., Memory impairment and neuronal dysfunction induced by β-amyloid protein in rats. Tohoku J. Exp. Med., 1994, 174, 241-249.
80. Namekata, K., Imagawa, M., Terashi, A., Ohta, S., Oyama, F. and Ihara, Y., Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum. Genet., 1997, 101, 126-129.
81. Nitsch, R. M., Farber, S. A., Growdon, J. H. and Wurtman, R. J., Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl Acad. Sci. U.S.A., 1993, 90, 5191-5193.
82. Rossner, S., Ueberham, U., Yu, J., Kirazov, L., Schliebs, R., Perez-Polo, J. R. and Bigl, V., In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur. J. Neurosci., 1997, 9, 2125-2134.
83. Nitta, A., Itoh, A., Hasegawa, T. and Nabeshima, T., β-amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett., 1994, 170, 63-66.
84. Pedersen, W. A., Kloczewiak, M. A. and Blusztajn, J. K., Amyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc. Natl Acad. Sci. U.S.A., 1996, 93, 8068-8071.
85. Pedersen, W., Guo, Q., Hartman, B. K. and Mattson, M. P., NGF-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1. J. Biol. Chem., 1997, 272, 22,397-22,400.
86. Pedersen, W. A. and Blusztajn, J. K., Characterization of the acetylcholine-reducing effect of the amyloid-β peptide in mouse SN56 cells. Neurosci. Lett., 1997, 239, 77-80.
87. Roch, J. M., Masliah, E., Roch-Levecq, A. C., Sundsmo, M. P., Otero, D. A., Veinbergs, I. and Saitoh, T., Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc. Natl Acad. Sci. U.S.A., 1994, 91, 7450-7454.
88. Roth, G. S., Joseph, J. A. and Mason, R. P., Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci., 1995, 18, 203-206.
89. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S. and Thai, L. J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med., 1997, 336, 1216-1222.
90. Singer, C. A., McMillan, P. J., Dobie, D. J. and Dorsa, D.M., Effects of estrogen replacement on choline acetyltransferase and trkA mRNA expression in the basal forebrain of aged rats. Brain Res., 1998, 789, 343-346.
91. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. and Markesbery, W. R., Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl Acad. Sci. U.S.A., 1991, 88, 10,540-10,543.
92. Smith, M. A., Harris, P. L. R., Sayre, L. M., Beckman, J. S. and Perry, G., Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci., 1997, 17, 2653-2657.
93. Smith-Swintosky, V. L., Pettigrew, L. C., Craddock, S. D., Culwell, A. R., Rydel, R. E. and Mattson, M. P., Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem., 1994, 63, 781-784.
94. Sohal, R. S. and Weindruch, R., Oxidative stress, caloric restriction, and aging. Science, 1996, 273, 59-63.
95. Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H. and Mayeux, R., Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 1996, 348, 429-432.
96. 56Fe irradiation diminishes muscarinic, but not α1-adrenergic stimulated low-Km GTPase in rat brain. Radiation Res., 1994, 140, 382-386.
97. Warpman, U., Alafuzoff, I. and Nordberg, A., Coupling of muscarinic receptors to GTP proteins in postmortem human brain - alterations in Alzheimer's disease. Neurosci. Lett., 1993, 150, 39-43.
98. Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J. K., Lacana, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W. and D'Adamio, L., Participation of presenilin 2 in apoptosis : enhanced basal activity conferred by an Alzheimer mutation. Science, 1996, 274, 1710-1713.
99. Yanker, B. A., Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 1996, 16, 921-932.